Friday, April 24, 2020

Debunking The Hydroxychloroquine "Controversy"

The FDA said it was issuing the warning after reports that patients taking the drugs, especially in combination with the antibiotic azithromycin, had experienced heart issues.

"The FDA is aware of reports of serious heart rhythm problems in patients with Covid-19 treated with hydroxychloroquine or chloroquine, often in combination with azithromycin," the health agency said in the warning.

The cost of hydroxychloroquine ingredients is soaring.

Cadila Healthcare managing director Sharvil Patel said contracts with Chinese suppliers of ingredients for hydroxychloroquine production had not been honored as they were signed and suppliers were asking to pay multiple times more, Financial Times reports, citing an interview with the executive.

Anhui Haihua Chemical Technology, a Chinese supplier of hydroxychloroquine ingredient m-chloroaniline, confirmed the product's 375% price increase to about $26,840 a ton since the start of the year, FT says citing an identified official at the company.

There sure has been a lot of recent press about how ineffective hydroxychloroquine is.

It wasn't randomized; by its own admission, hydroxychloroquine was given to sicker patients, closer to death, when we know HCQ works best when given early on.

https://www.zerohedge.com/health/debunking-hydroxychloroquine-controversy

No comments: